In addition, the high levels of AR expression in the IACs makes this receptor a promising anticancer therapeutic target for this type of breast cancer, but the ability to exploit AR for therapy remains to be challenging [55], [56], [57], [58]. The gene discussed is AR; the disease is breast cancer.